Gene: HTRA3
Official Full Name: HtrA serine peptidase 3provided by HGNC
Gene Summary: Enables endopeptidase activity; identical protein binding activity; and serine-type peptidase activity. Involved in proteolysis. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22098 | HTRA3 Knockout cell line (HeLa) | Human | HTRA3 | 1:3~1:6 | Negative | Online Inquiry |
KO22099 | HTRA3 Knockout cell line (HEK293) | Human | HTRA3 | 1:3~1:6 | Negative | Online Inquiry |
KO22100 | HTRA3 Knockout cell line (A549) | Human | HTRA3 | 1:3~1:4 | Negative | Online Inquiry |
HTRA3 Gene Knockout Cell Lines are engineered cellular models that have been specifically designed to lack the expression of the HTRA3 gene, which encodes a serine protease implicated in various biological processes, including extracellular matrix remodeling and regulation of programmed cell death. These cell lines enable researchers to investigate the functional role of HTRA3 in cellular stress responses, tumorigenesis, and other pathophysiological conditions.
The key mechanism of HTRA3 is its involvement in the proteolytic processing of extracellular proteins, thereby influencing multiple signaling pathways. By using knockout cell lines, scientists can elucidate the gene's contribution to specific protein interactions and downstream cellular impacts without the confounding effects of HTRA3 expression. This functional specificity is paramount in studies exploring cancer biology and therapeutic development.
In terms of scientific importance, HTRA3 Gene Knockout Cell Lines serve as invaluable tools in biomedical research. They are particularly useful in elucidating the gene's role in diseases such as cancer, where altered protease activity can lead to tumor progression and metastasis. By providing insights into the molecular mechanisms at play, these cell lines may pave the way for novel therapeutic strategies and biomarker discovery.
One significant advantage of our HTRA3 Gene Knockout Cell Lines is the reliability and reproducibility of research outcomes compared to other techniques, such as transient siRNA knockdown, which can yield inconsistent results due to variable silencing efficiency. Additionally, these knockout models are optimized for various applications, including drug screening, gene expression studies, and mechanistic investigations, offering a comprehensive platform for a wide array of experimental designs.
For researchers and clinicians, the value of HTRA3 Gene Knockout Cell Lines lies in their ability to accelerate discovery while reducing the variability associated with experimental models. Their specificity ensures that data obtained can be attributed directly to the functional loss of HTRA3, making them essential for achieving actionable insights.
Our company, with extensive expertise in developing advanced genetic models and a commitment to quality, is proud to offer these HTRA3 Gene Knockout Cell Lines as part of our comprehensive biological product portfolio. We are dedicated to equipping scientists with the tools necessary to drive innovation and achieve breakthroughs in research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.